Average Co-Inventor Count = 3.70
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Lexicon Pharmaceuticals, Inc. (10 from 86 patents)
2. Merck + Co., Inc. (4 from 4,770 patents)
3. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
15 patents:
1. 12344596 - Solid forms of (S)-1-((2',6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof
2. 12312325 - Methods and compounds useful in the synthesis of an AAK1 inhibitor
3. 10968192 - Crystalline solid forms of N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)butanamide and methods of their synthesis
4. 9067962 - Methods of treating diabetes
5. 8772483 - Solid forms of (S)-2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid
6. 8450532 - Compounds useful in the preparation of tryptophan hydroxylase inhibitors
7. 8293878 - Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
8. 8217156 - Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use
9. 8026347 - Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
10. 7897763 - Process for the preparation of substituted phenylalanines
11. 7875642 - Crystalline forms of an inhibitor of 11-β-hydroxysteroid dehydrogenase type 1
12. 6924291 - Process for making spiro isobenzofuranone compounds
13. 6872724 - Polymorphs with tyrosine kinase activity
14. 6600040 - Process for the synthesis of (2R, 2-alpha-R, 3A)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1, 4-oxazine
15. 6395898 - Trans-glycosidation process for the synthesis of (2R, 2-alpha-R, 3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine